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Previous studies proved the importance of rapid antibacterial intervention in case of Pseudomonas aeruginosa detection in respiratory samples
of cystic fibrosis patients. To improve the early detection of P. aeruginosa, several culture, PCR and serology based approaches have been
compared. Because an increasing number of routine microbiology laboratories have access to real-time PCR (qPCR), we reviewed the specificity
and sensitivity of published PCR formats. The importance of choice of DNA-extraction methods and PCR formats and of the validation of their
specificity and sensitivity with clinical samples is stressed.
© 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Pseudomonas aeruginosa; Cystic fibrosis; PCR; Early detection
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Chronic lung colonization with Pseudomonas aeruginosa is
the major cause of morbidity and mortality among cystic fibrosis
(CF) patients. The finding that early aggressive antibiotic
treatment, in case of a first-ever P. aeruginosa isolation, is crucial
in order to prevent or to postpone chronic lung colonization, has
increased the importance and necessity of rapid and sensitive
detection techniques [1–4]. To date, in most routine laboratories,
detection of P. aeruginosa is still carried out by microbiological⁎ Corresponding author. Tel.: +32 9 332 3692; fax: +32 9 332 3659.
E-mail address: Deschaght.Pieter@UGent.be (P. Deschaght).
1569-1993/$ - see front matter © 2011 European Cystic Fibrosis Society. Publishe
doi:10.1016/j.jcf.2011.05.004culture. Although a comparative study has shown that culture is a
reliable detection technique [5], still, microbiologists are searching
for a more rapid and sensitive way to detect P. aeruginosa
from CF airway samples [6]. During the last decade, DNA
amplification opportunities for the detection of P. aeruginosa in
respiratory samples of CF patients have increased substantially.
Consequently, several studies have addressed the comparison of
the specificity and the sensitivity of culture techniques and PCR
techniques [6,7]. Also with regard to the transmission of clonal
P. aeruginosa strains among CF patients (such as the Liverpool
strain), PCR may be useful since identification of these clones
using a specific PCR can be achieved, which is not possible
by means of culture [8–10]. These publications also indicated by Elsevier B.V. All rights reserved.
Table 1
Summary of the tested primer pairs with regard to their specificity for
P. aeruginosa detection by means of PCR.
Author Isolates
tested
Species
tested
PCR target Number of positive
reactions/number tested
isolates
P.
aeruginosa
non P.
aeruginosa
Lavenir
et al. [11]
74 16 gyrB 59/59 0/15
toxA 55/59 0/15
16S-23S
rDNA ITS
59/59 0/15
16S rDNA 59/59 1/15
oprI 59/59 3/15
oprL 59/59 2/15
fliC 59/59 13/15
ecfX 59/59 0/15
De Vos
et al. [12]
220 36 oprL 150/150 0/70
Jaffe et al. [13] 58 14 oprL 40/40 0/18
Anuj et al. [14] 91 10 ecfX+gyrB 63/63 0/28
ecfX 63/63 0/28
gyrB 63/63 0/28
oprL 63/63 4/28
ETA 62/63 0/28
16S rDNA 63/63 2/28
Qin et al. [15] 200 5 gyrB 113/113 0/87
algD GDP
mannose
101/113 0/87
oprI 112/113 1/87
ETA 108/113 0/87
Motoshima
et al. [16]
224 ND gyrB 104/104 0/120
da Silva Filho
et al. [18]
202 11 algD GDP
mannose
176/176 0/26
da Silva Filho
et al. [19]
54 18 algD GDP
mannose
7/7 0/47
ND: not determined.
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are crucial. Here, we review the different approaches, their
possibilities and shortcomings, and we highlight some caveats
when interpreting the sensitivity of the different approaches.
We searched the PubMed online database using the keywords
of this manuscript.
2. Specificity of the qPCR format
Different selective media with their own specificity have
been developed for microbiological culture. For PCR as well,
different species specific genes have been targeted, whereby
specificity is largely determined by primer choice. Although the
specificity of a PCR format can be influenced by multiple
factors, such as Mg2+ and NaCl concentration, it is essential to
develop primers that only bind the target gene of the selected
species. Several studies tested one or more primer pairs on a
selection of isolates from different species, as summarized in
Table 1. Regarding the specificity of P. aeruginosa PCR
formats, seven groups tested primer pairs, targeting a total of 10
different P. aeruginosa genes, using different bacterial species
as specificity controls. For the primer pair targeting the fliC
gene the specificity was very low, since 13 of a panel of 15
Pseudomonas (non-P. aeruginosa) species yielded a positive
PCR result [11]. Four studies tested the specificity of the oprL
primer pair, developed by De Vos and colleagues [12]. In the
studies of De Vos et al. [12] and Jaffe et al. [13], no cross reaction
with non-P. aeruginosa isolates was detected, while in the study
of Anuj et al. [14], unspecific amplification for four species
(Achromobacter xylosoxidans, Ralstonia pickettii, Shewanella
spp. and Pseudomonas fluorescens) was reported, although in the
studies of De Vos et al. [12] and Jaffe et al. [13], P. fluorescens
and R. picketii were also tested and no unspecific amplification
was detected. It should be noted that in the study of Anuj et al.
[14], detection was performed with hybridization probes, while
in the other studies no probes were used. In the study of Lavenir et
al. [11], unspecific amplification was detected with the oprL
primers for Pseudomonas balearica and Pseudomonas citronel-
lolis, whichmay pose little problems for CF studies, because these
are environmental isolates, not yet found in the CF-lung. Studies
testing the specificity of the PCR-format targeting the gyrB gene,
as developed by Qin et al. [15], using SYBR Green [11,16] or a
hydrolysis probe [14] found no unspecific amplification.
Overall, it can be concluded that most tested primer pairs,
except the fliC primer pair, have a high specificity. However, as
was shown for the oprL-PCR, it is of utmost importance to re-
validate the PCR-specificity when switching to another format,
e.g. when switching from SYBRGreen-based qPCR to hydrolysis
probe-based qPCR, or when switching to another thermal cycler.
3. Sensitivity of the qPCR formats
Another important point to be taken into consideration is the
sensitivity of the PCR format, when applied for detection of the
pathogen from clinical samples, more specifically for detection
of P. aeruginosa in respiratory samples of CF patients. The
development of a PCR with high specificity is not an inherentguarantee for its high sensitivity when applied to clinical
samples. Without affecting specificity, the sensitivity can be
influenced by the sampling procedure, the DNA-extraction
method or the PCR-conditions, whereby the latter may influence
dimerization of the primers and internal base pairing and folding
of the target DNA, which in turn may inhibit the binding of the
primers and the polymerase.
Sensitivity is (mostly) not an issue when high bacterial loads
are present, but low concentrations, as may be found in recently
colonized CF patients, i.e. the type of patients for whom early
detection is crucial, might be missed.
Most of the studies, comparing the sensitivity of culture and
PCR for the detection of P. aeruginosa, are cross-sectional
[11,12,16–21]. In all of these studies, an equal or increased
detection rate was found with PCR in comparison with culture
(Table 2). Unfortunately, in most articles the description of the
DNA-extractionmethod used is too limitedwith regard the sample
volume input and the DNA elution volume output. Therefore it is
not possible to determine the maximum initial input of bacterial
chromosomes into the PCR mixture, which makes it difficult to
compare the absolute efficacies of the different PCR formats.
Table 2
Culture and PCR positivity for the detection of P. aeruginosa in clinical (and environmental) samples in cross-sectional studies.
Author Sample type PCR target Number of
samples
Culture
positive
PCR
positive
Extraction method
Lavenir et al. [11] Environmental gyrB 41 5 3 FastDNA SPIN Kit (qBiogene)
ecfX 41 5 8
16S-23S rDNA ITS 41 5 7
De Vos et al. [12] Sputum oprL 49 40 44 Phenol–chloroform or boiling
Skin biopsies oprL 14 7 9
Motoshima et al. [16] Sputum gyrB 108 54 56 QIAamp DNA Mini Kit (Qiagen)
Karpati et al. [17] Sputum 16S rDNA 90 40 45 Amplicor Sputum Specimen
Preparation Kit (Roche)
da Silva Filho et al. [18] Sputum algD GDP mannose 10 5 5 Freezing–boiling
Throat algD GDP mannose 5 2 2
da Silva Filho et al. [19] Sputum, OS b algD GDP mannose 257 144 200 Phenol–chloroform
da Silva Filho et al. [20] Sputum, OS b algD GDP mannose 87 a 42 53 Phenol–chloroform
Zemanick et al. [21] Sputum 16S rDNA 82 40 44 Phenol–chloroform
OS b 16S rDNA 40 16 10
a Patients, number of samples not specified.
b Oropharyngeal swab.
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decade, regarding the early detection of P. aeruginosa in CF
patients (Table 3). The first study was published by Xu and
colleagues [22], who followed 57 not colonized adult CF
patients. For twenty-five patients, samples were positive by
culture and PCR, while for five patients, at least one sample was
found only positive by culture and for 10 patients only positive
by PCR. Follow-up of the latter 10 patients showed that
5 patients converted to culture positivity after 4–17 months
(Table 3). In 2010, four follow-up studies were published.
Also in these studies, a significant part of the samples were
found qPCR positive/culture negative (median: 5.85%, mean:
8.19%, range: 2.24%–23.8%) (Table 3). In one study, none of
the six culture negative/qPCR positive patients converted to
culture positivity, but in the other three studies, part of the
qPCR positive/culture negative samples (median: 19.2%, mean:
19.8%, range: 10.0%–38.5%) had at least one follow-up sample
which was also positive for culture (Table 3). This may suggest
that in some cases, qPCR is able to detect P. aeruginosa earlier
in comparison to culture. A drawback of these follow-up studiesTable 3
PCR and culture detection results in follow-up studies.
Author Sample type PCR target Number of patients
Xu et al. [22] Sputum oprL 57 (ND)
ETA 57 (ND)
Logan et al. [24] a Sputum gyrB+algD 183 (851)
Throat swabs gyrB+algD 183 (1248)
Billard-Pomares et al. [25] b Sputum oprL 17 (72)
Deschaght et al. [26] Sputum, NA e,
throat swab
oprL 397 (852)
McCulloch et al. [27] Cough swabs 23S rDNA 161 (500)
Sputum 23S rDNA 25 (42)
ND: not determined.
a DNA-extracts were 2.5 fold concentrated in comparison with culture samples.
b DNA-extracts were 10-fold concentrated in comparison with culture samples.
c Patients, number of samples not specified.
d C+: culture positive follow-up samples.
e nasopharyngeal aspirate.is that it cannot be confirmed that the strain cultured later on,
after a first PCR positive/culture negative result, was genotyp-
ically identical to the strain causing the first PCR positive/
culture negative result. This cannot be confirmed, because of
lack of an isolate at the first PCR positive result. Moreover, in
light of the long period until culture positivity, it is possible that
the culture positive result later on was caused by colonization
with an unrelated strain, a not unlikely event, given the relatively
high conversion rate to P. aeruginosa culture positivity among
not-yet-colonized CF patients.
Interestingly, in most studies there were also several samples
with P. aeruginosa culture positive/PCR negative results
(Table 3), which indicates that – in order to achieve maximal
sensitivity – both techniques ideally should be combined, as
was also concluded by Döring et al. [23].
It should be noted that the specimen processing may also
influence the conclusions regarding sensitivity of PCR versus
culture, since in some studies [24,25] the respiratory sample was
centrifuged prior to DNA-extraction, as such concentrating
sample density 2.5-fold [24] and 10-fold [25], relative to the(samples) C− PCR− C+ PCR+ C+ PCR− (C+) d C− PCR+ (C+) d
17 25 5 (ND) 10 (5)
17 22 5 (ND) 3 (0)
452 260 6 (ND) 52 (20)
945 80 14 (ND) 28 (6)
17 c 0 0 (0) 6 c (0)
729 89 10 (2) 26 (5)
446 26 0 (0) 28 (3)
10 22 0 (0) 10 (1)
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cough swab, throat swab or nasopharyngeal aspirate, we found no
significant linkage between the sample type and dissimilarity
between qPCR and culture sensitivity [26], while Logan et al. [24]
and McCulloch et al. [27] found proportionally more qPCR
positive/culture negative sputum samples (resp. 6.1%and 23%) in
comparisonwith qPCRpositive/culture negative throat swabs and
cough swabs (resp. 2.2% and 6.2%). These differences between
the studies can be due to different swab types used and/or
differences in sample processing, but these items were not always
fully specified in the above articles. Based on our literature study,
not many research has been done concerning the ideal sampling
procedure, but in a study of Rogers and colleagues [28], no
differences were found concerning the bacterial content in
spontaneously expectorated sputum and (salbutamol and hyper-
tone salt inhalation)-induced sputum.
Recently, we compared different DNA-extraction methods
and different PCR-formats on a sputum dilution series [5],
targeting the oprL gene. The P. aeruginosa positive sputa,
derived from 2 chronically colonized CF patients, were pooled
and serially diluted in a pool of P. aeruginosa negative sputa in
order to mimic as closely as possible the sputum samples sent to
the routine laboratories. We were able to show the importance
of proteinase K pretreatment and of the DNA-extraction method
in maximizing the sensitivity. Moreover, the probe based (i.e.
hydrolysis probe and hybridization probe) assays were more
sensitive than SYBR Green-based qPCR detection and had a
detection limit of 50 cfu/ml, i.e. the lowest concentration that
theoretically can be detected, because it corresponds to the
presence of one genome (cell) per PCR reaction mixture (when
using 200 μl sputum of which the DNA was extracted in 50 μl
and 5 μl DNA extract was used in 15 μl PCR-mix) [5]. This
comparative methodological study showed the importance of
specimen processing, including the DNA extraction method,
and the choice of PCR format. These findings confirm the
statements made by Döring and colleagues that validation of
these techniques is necessary before they can be implemented in
the routine laboratory [23]. Another validation study was
carried out recently by Zemanick and colleagues [21]. They
tested qPCR assays for the detection of nine bacterial species,
including P. aeruginosa, on 158 respiratory samples from 16
CF-patients in triplicate and for different parts of the samples
and could conclude that detection of different bacteria in
respiratory samples with qPCR is highly reproducible.
4. Conclusions
Overall, all published reports indicate that qPCR is a useful
additional tool for the early detection for P. aeruginosa in not
chronically infectedCFpatients. In all studies, PCRpositive/culture
negative samples were found, but in almost all studies also culture
positive/PCR negative samples were found. Although we need to
know what the cost benefits are for carrying out both culture
and PCR for maximizing the sensitivity of detecting early
P. aeruginosa colonization of CF airways, and we certainly need
to understand better the clinical implications of discrepant results,
it may be on the safe side to consider combining both approachesfor detection and to consider antibiotic treatment whenever one of
both approaches indicates the presence of this species. In order to
assess the clinical relevance of this early PCR detection, studies to
monitor the effect of treatment of the patients with a discrepant
result should be carried out. The different studies also revealed
that before implementation in routine laboratories, validation of
sampling, DNA-extraction and qPCR format is necessary to
optimize the sensitivity of the molecular techniques.References
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